Virtual Learning Event

All Oncologists in the West Coast area of the US are invited to attend a Virtual Product Presentation hosted by BMS. It will be held as a virtual event on Wednesday, July 22, 2020 at 5:00pm Pacific Time.

“A Treatment Option for the Management of Certain Patients with First Line Non-small Cell Lung Cancer and Unresectable or Metastatic Melanoma” with Featured Speaker, Dr. Steven John O’Day.

For complete event information and to register for free today visit: BMS Virtual Product Presentation

The Kimpton Sawyer Hotel
Sacramento, CA

As a result of prior course participant evaluations and needs assessment surveys, the need for cutting edge information on prognostic markers and appropriate application of novel therapies has been identified. This year’s conference will specifically address these needs in the common malignancies identified by past participants as essential to their practice, including solid and hematologic cancers. The timing of this meeting in the fall allows for the latest findings in clinical cancer research from major hematology and oncology conferences to be presented and discussed. This educational activity also meets a unique need for the Northern California Sacramento Valley to provide a group of networked and collaborating oncologists a forum to discuss the most recent developments in oncology care in the context of local treatment approaches, patient populations, and open clinical trials.

For complete conference details, to register and reserve your hotel room, visit: 2020 Advances in Oncology

The Langham Huntington Hotel

Pasadena, CA

This conference will bring together top oncologists for a comprehensive review and updated data in hematology, medical oncology, gynecology malignancies, immunotherapy, supportive care, healthcare policies and novel technologies in cancer management. This conference aims to provide up-to-date information to the clinician regarding new advances in cancer biology, diagnosis, and treatment. It will bring together respected opinion leaders, practicing clinicians and scientists engaged in clinical cancer research to discuss the latest cancer diagnostic and therapeutic advances.

For complete conference information, to register and reserve your hotel room, visit: CCC 2020

The Roosevelt New Orleans Hotel

New Orleans, LA

The 15^th Annual New Orleans Summer Cancer Meeting (NOSCM) is a major CME/CE event well established in the Southeast region of the United States. In 2020, the meeting has innovations: simultaneous sessions running in parallel, one for physicians and the other one for nurses. Also, a special emphasis has been dedicated to immunotherapy as more clinical indications are coming up as well as different therapeutic compounds with different companion diagnostic tests which require a careful review on the clinical data. Moreover, based on evaluations from the previous 14 consecutive years, this meeting will provide healthcare professionals taking care of cancer patients with the necessary tools to offer the best quality of care to their patients. The 15^th edition of this national CME/CE program will focus on integrating major advances in basic sciences and how to apply them into the routine clinical practice, and hence, deliver customized therapy to each individual patient. In 2020, the Educational Committee decided to continue with topics such as brain tumor, sarcoma, gynecologic malignancies, and geriatric oncology and best supportive of care. As we know, all progress in oncology will not be possible if we do not have the support from novel technology in radiation therapy as well as new diagnostic tools such as liquid biopsy. In the 15^th Annual NOSCM, discussion on these techniques will take place. The hematology session in 2020 will have the participation of renowned hematologists who will cover the major hematologic malignancies including lymphoma, myeloma and leukemias.

For complete conference information, to register and reserve your hotel room, visit: NOSCM 2020

Westin Pasadena
Pasadena, California

This Master Lecture Series (MLS) will provide current, practical information on the management of immunotherapy and target therapies. Novel agents and strategies will be discussed with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), Melanoma, Lung (RET/MET/ VEGFR2) & breast cancer (HER2 PI3K/Akt). Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

This Master Lecture Series is a one-day program designed for medical oncologists, radiation oncologists, surgical oncologists, advanced registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties will also be in attendance.

Complete conference details, hotel and registration information are coming soon.

Hilton Hawaiian Village Waikiki Beach Resort
Honolulu, Hawaii

The 6th Annual Practical Recommendations in Immuno and Molecular Oncology (PRIMO) Meeting is designed to summarize key developments in cancer care over the past 12 months and features anticipated advances that HCPs will likely see in the upcoming year.

Secure your spot and join our distinguished faculty at the PRIMO meeting in Honolulu, Hawaii on February 10 – 13, 2021 and participate in the discussion regarding:

• Practical considerations of applying biomarkers and targeted therapy
• Integration of immunotherapy with a focus on novel management approaches
• Patient selection, as well as timing and sequencing of therapy
• Dealing with important trends such as big data and defining value in cancer care

Complete conference details, hotel and registration information are coming soon.

Venue TBC
New Orleans, Louisiana

This Master Lecture Series (MLS) will provide current, practical information on the management of immunotherapy and target therapies. Novel agents and strategies will be discussed with the potential to shape the future of cancer therapy. Leading experts will address critical topics in personalized therapy, and the latest clinical data impacting the treatment of GI, GU (PAR Inhibitors), Melanoma, Lung (RET/MET/ VEGFR2) & breast cancer (HER2 PI3K/Akt). Cutting-edge lectures, panel discussions, multidisciplinary tumor boards with lively and collaborative question-and-answer sessions will provide a unique opportunity for participants to interact with faculty as they share their viewpoints and personal practices on the clinical challenges and ongoing controversies in managing cancer patients. The audience will engage in case-based discussions and critical deliberations on the state of current knowledge, clinical findings, differential diagnoses and management plan options for their patients.

This Master Lecture Series is a one-day program designed for medical oncologists, radiation oncologists, surgical oncologists, advanced registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties will also be in attendance.

Complete conference details, hotel and registration information are coming soon.

La Concha Renaissance Hotel
San Juan, Puerto Rico

This three-day conference is designed for medical oncologists, radiation oncologists, surgical oncologists, advanced registered nurse practitioners (ARNP), physician assistants (PA0, oncology nurses, registered pharmacists, pharmacy technicians and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties are encouraged to attend. Topics in breast cancer, gastrointestinal (GI) malignancies, head and neck cancers, hematological malignancies (i.e., multiple myeloma, CLL, CML, non-Hodgkin’s lymphoma) genito-urinary (GU) cancers, brain tumors, malignant melanoma, and non-small cell lung cancer (NSCLC) will be presented.

The areas of focus for this conference will include the review of current standards of care in the treatment of all malignancies and new developments in cancer care. There will be an emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. Presentations from latest national and international meetings will be reviewed and guidelines of cancer care will be emphasized.

Complete conference details, hotel and registration information will be coming soon.

Venue TBC
San Francisco, California

Conference information, hotel and registration information are coming soon.

Trump National Doral
Miami, Florida

This three-day conference is designed for medical oncologists, radiation oncologists, surgical oncologists, advances registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit of a review of the standard of care and new developments in cancer therapy. Residents in training and fellows from these specialties are encouraged to attend.

Topics in breast cancer, gastrointestinal (GI) malignancies, head and neck cancers, hematological malignancies (i.e., multiple myeloma, CLL, CML, and Non-Hodgkin’s lymphoma) genito-urinary cancers (GU), brain tumors, malignant melanoma, and non-small cell lung cancer (NSCLC) will be presented. The areas of focus for this conference will include the review of current standards of care in the treatment of all malignancies and new developments in cancer care. There will be an emphasis on molecular diagnosis and individualization of cancer therapy based on molecular profiles. Presentations from latest national and international meetings will be reviewed and guidelines of cancer care will be emphasized.

 
For conference details, to register to the event and make your hotel reservation, visit 2021 MCM

The Roosevelt New Orleans Hotel

New Orleans, LA

Conference information, registration and hotel reservation information coming soon.